Morgan Stanley’s Molekule Group, Inc. Common Stock MKUL Stock Holding History

Morgan Stanley’s Portfolio MKUL Stock Details MKUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,000	Closed	-$435	–	8048
2023 Q3	$435	Hold	3,000	–	–	﹤0.01%	7321
2023 Q2	$7.02K	Hold	3,000	–	–	﹤0.01%	6913
2023 Q1	$5.07K	Sell	3,000 -1,011	-25%	-$2.61K	﹤0.01%	7049
2022 Q4	$12.6K	Sell	4,011 -8,751	-69%	-$29K	﹤0.01%	6856
2022 Q3	$37K	Buy	12,762 +8,862	+227%	+$53.5K	﹤0.01%	6549
2022 Q2	$51K	Buy	3,900 +460	+13%	+$2.71K	﹤0.01%	6607
2022 Q1	$12K	Buy	3,440 +3,001	+684%	+$15.4K	﹤0.01%	7362
2021 Q4	$5K	Buy	+439	New	+$9.65K	﹤0.01%	7662

Other funds holding MKUL

FGN

Foundry Group Next Boulder, Colorado $21.1M AUM 35.51% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

SFG

SVB Financial Group Dallas, Texas $434K AUM 277.67% 1-Year Est. Return

Morgan Stanley's MKUL Position: Q4 2023 in Review

Morgan Stanley sold out of Molekule Group, Inc. Common Stock (MKUL) in Q4 2023, closing a stake of 3,000 shares — an estimated $435 sold.

Morgan Stanley first reported a position in MKUL in Q4 2021 and held it in 8 quarters. The position peaked at $51K in Q2 2022. 3 funds tracked by Wall St. Rank hold MKUL as of Q4 2023.

Morgan Stanley reported no remaining Molekule Group, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Morgan Stanley sold 3,000 Molekule Group, Inc. Common Stock shares in Q4 2023, an estimated $435.
Morgan Stanley first reported a position in Molekule Group, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
Morgan Stanley's Molekule Group, Inc. Common Stock position peaked at $51K in Q2 2022.
3 funds tracked by Wall St. Rank held Molekule Group, Inc. Common Stock as of Q4 2023.

Based on Morgan Stanley's 13F filing for Q4 2023, filed 13 Feb 2024.